Rubicon announces further ArborGen expansion
To: NZX From: Mark Taylor
Telephone: 64-9-356 9800
Further information on Rubicon Limited can be viewed at the Rubicon web site, at http://www.rubicon-nz.com.
Rubicon announces further ArborGen expansion
1 November, 2018 – Rubicon announced today that ArborGen Inc (“ArborGen”) has entered into a
series of agreements with certain subsidiaries of TexMark Timber Treasury, L.P. (“Triple T”) - a joint
venture between CatchMark Timber Trust, Inc. and a consortium of large institutional investors, that
recently completed the acquisition of Campbell Global’s US$1.4 billion of timberlands located in Texas,
US.
The primary agreement is a lease, pursuant to which ArborGen will lease the Triple T nursery and seed
orchard properties located in Texas. This agreement includes a call option that gives ArborGen the
right to acquire the leased properties, and a corresponding put option that gives Triple T the right to
sell the leased properties, for US$2.5 million payable upon the expiration of the 5-year lease period.
ArborGen’s current intention is that it will exercise the call option at the end of the lease period. The
lease agreement (and subsequent call option exercise) will allow ArborGen to increase its annual
nursery production capacity and sales by approximately 30 million seedlings per annum (effective
from the next production season beginning 1 April 2019 when the lease agreement takes effect), and
also immediately expand its productive seed-orchard capacity (including advanced genetics seed) in
the important Texas region.
ArborGen has also entered into an exclusive multi-year agreement to supply Triple T all of its Texas
seedling requirements for an initial term of 5 years, with term-renewal periods thereafter.
Dave Knott, the ArborGen and Rubicon Chairman, said, “We are delighted to partner with Triple T and
expand our productive capacity in a core loblolly plantation area in the US Southeast. This new
relationship with Triple T will allow us to make our broad portfolio of loblolly seedling genetics more
accessible to landowners in the Texas region, and we look forward to providing our industry expertise
and customer service to these landowners.” The Triple T nursery will become the eighth operational
nursery location for ArborGen in the US-South, further expanding its advanced genetics loblolly
seedlings supply in the Southeast.
About ArborGen
ArborGen is the largest commercial global seedling supplier and a leading provider of advanced genetics, for the
forest industry. Employing state-of-the-art technology, ArborGen is developing high-value products that
significantly improve the productivity of forestry. For more information, please visit ArborGen’s website at
www.arborgen.com.
EOF
Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.
Other issuers discussed similar conditions around this time
Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.
- GEN — General Capital Limited: General Capital Limited (GEN:NZ) Capital Raising Update2018-12-06
“General Capital Limited Level 7, 12-26 Swanson Street, PO Box 1314, Shortland Street, Auckland, New Zealand. 1140. Phone +64 9 304 0145 Fax +64 9 358 3858 General Capital Limited (GEN:NZ) Capital Raising Update General Capital advises that it has successfully complet…”
- GEN — General Capital Limited: General Capital Limited (GEN:NZ) Capital Raising Update cor2018-12-26
“General Capital Limited Level 7, 12-26 Swanson Street, PO Box 1314, Shortland Street, Auckland, New Zealand. 1140. Phone +64 9 304 0145 Fax +64 9 358 3858 General Capital Limited (GEN:NZ) Capital Raising Update General Capital advises that it has successfully complet…”
- PHL — Promisia Healthcare Limited: Release of Offer Document and Updated Issue Timetable2018-12-05
“9547635_1 6 Sales of both Arthrem and Artevite have been slow due to the lack of promotional spending other than pharmacy chain promotions and instore sales support. Funding In January 2018 the company raised $955,000 from a placement of Shares. This funding e…”